Tuesday, May 29, 2012 12:57:17 PM
http://ovcare.ca/Anglesio_personal_copy_OCCC_REVIEW_Final.pdf
Since the 2076 trials to date seem to indicate a better result in the clear cell patients ( I do not necessarily equate "better" with "good") the article might be intersting. While the molecular references are beyond me I thought the observation that Asian women seem be more susceptible to "CCC" perhaps suggests that continuing trials in that part of the world will produce more encouraging data for 2076.
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM